News & Events

- BioDlink’s bevacizumab injection secures marketing authorization in Colombia and Pakistan followingits recent approval in Nigeria, marking key regulatory milestones in high-needemerging markets.- GMP certification in Brazil, Colombia,and Argentina spans

- BioDlink convenes a peer advisory eventbringing together biotech CEOs, MNC leaders and researchers to discussinnovation and collaboration strategies- Integrated one-stop technology platformhelps innovative biotech companies launch life-saving therapies

BioDlinks Bevacizumab Injection has been granted marketing authorization by Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC), following GMP certifications in Brazil (a PIC/S member), Colombia, Egypt, Indonesia, and Argenti……

GMP certification from Argentina, marking a key step in its global expansion and regulatory recognition

Demonstrated BioDlink’s capability to develop and deliver globally trusted biosimilars,especially antibody drugs, with proven consistency and reliability

BioDlink provided end-to-end development and manufacturing support, showcasing its industry-leading ADC capabilities.